Title: Cardiovascular Risk of Celecoxib no Worse Than That of Ibuprofen or Naproxen
Abstract: Data from a long-term prospective, randomized trial comparing the cardiovascular safety of celecoxib with that of ibuprofen and naproxen have shown that celecoxib carries no greater risk of clot-related cardiovascular events. The dosage studied was low, 100 mg twice a day, and the safety of higher dosages has not yet been studied.
Publication Year: 2018
Publication Date: 2018-10-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 3
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot